Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictive and Prognostic Factors in Ovarian and Uterine Carcinosarcomas.
Cicin İ, Özatlı T, Türkmen E, Özturk T, Özçelik M, Çabuk D, Gökdurnalı A, Balvan Ö, Yıldız Y, Şeker M, Özdemir N, Yapar B, Tanrıverdi Ö, Günaydin Y, Menekşe S, Öksüzoğlu B, Aksoy A, Erdogan B, Bekir Hacıoglu M, Arpaci E, Sevinç A. Cicin İ, et al. Among authors: balvan o. Balkan Med J. 2016 Sep;33(5):517-524. doi: 10.5152/balkanmedj.2016.151268. Epub 2016 Sep 1. Balkan Med J. 2016. PMID: 27761279 Free PMC article.
Clinical Features and Prognostic Factors of Metastatic Non-Clear Cell Renal Cell Carcinoma: A Multicenter Study from the Turkish Oncology Group Kidney Cancer Consortium.
Erol C, Yekedüz E, Tural D, Karakaya S, Şentürk Öztaş N, Uçar G, Kılıçkap S, Ertürk İ, Sever ÖN, Arslan Ç, Küçükarda A, Can O, Balvan Ö, Yazgan SC, Özgüroğlu M, Öksüzoğlu B, Şendur MAN, Ürün Y. Erol C, et al. Among authors: balvan o. Urol Int. 2023;107(6):595-601. doi: 10.1159/000528994. Epub 2023 Mar 30. Urol Int. 2023. PMID: 36996793
Adjuvant systemic chemotherapy with or without bevacizumab in patients with resected pulmonary metastases from colorectal cancer.
Turan N, Benekli M, Dane F, Unal OU, Kara HV, Koca D, Balvan O, Eren T, Tastekin D, Helvaci K, Berk V, Demirci U, Ozturk SC, Dogan E, Cetin B, Kucukoner M, Tonyali O, Tufan G, Oztop I, Gumus M, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Turan N, et al. Among authors: balvan o. Thorac Cancer. 2014 Sep;5(5):398-404. doi: 10.1111/1759-7714.12107. Epub 2014 Aug 25. Thorac Cancer. 2014. PMID: 26763794 Free PMC article.
Comparison of second-line treatment outcomes between sensitive and refractory small cell lung cancer patients: a retrospective analysis.
Korkmaz T, Seber S, Kefeli U, Sari E, Canhoroz M, Oven B, Yildirim E, Yasar N, Aydin D, Balvan O, Sener N, Yuksel S, Mert A, Polat O, Yumuk F, Kanat O, Gumus M, Turhal NS. Korkmaz T, et al. Among authors: balvan o. Clin Transl Oncol. 2013 Jul;15(7):535-40. doi: 10.1007/s12094-012-0960-6. Epub 2012 Nov 10. Clin Transl Oncol. 2013. PMID: 23143955
Prognostic significance of mucinous histology in left‑sided metastatic colorectal cancers with wild‑type RAS and evaluation of backbone chemotherapy regimens.
Arikan R, Atci MM, Ay S, Ayhan M, Demircan NC, Telli TA, Çelebi A, Yaşar A, Işik S, Celikel C, Balvan O, Bayoglu IV, Kostek O, Dane F, Yumuk PF. Arikan R, et al. Among authors: balvan o. Oncol Lett. 2023 Apr 5;25(5):208. doi: 10.3892/ol.2023.13795. eCollection 2023 May. Oncol Lett. 2023. PMID: 37123028 Free PMC article.
Clinicopathologic Features And Efficacy Of Induction Chemotherapy In Nasopharyngeal Carcinoma: Real-World Experience.
Majidova N, Sari M, Kahvecıglu FA, Ozcan E, Akdag MO, Dogan A, Yıldırım S, Sonusen SD, Yunusov E, Yasar A, Celebi A, Sever N, Kocaaslan E, Erel P, Agyol Y, Guren AK, Arikan R, Işık S, Balvan O, Geredeli C, Uygun K, Hacıbekiroğlu I, Kostek O, Bayoğlu İV. Majidova N, et al. Among authors: balvan o. Oncol Res Treat. 2024 Apr 2. doi: 10.1159/000537988. Online ahead of print. Oncol Res Treat. 2024. PMID: 38565096